The global allergy treatment market is poised for substantial growth, driven by rising allergy prevalence, advancements in medical science, and evolving treatment options. This market is projected to reach a value of US$ 34.9 billion by 2034, expanding at a CAGR of 5.8%. Factors like changing lifestyles, poor air quality, and increasing pollution contribute to the rising number of allergy sufferers, fueling demand for effective treatments.
A reactor blast at a pharmaceutical company in Andhra Pradesh’s Atchutapuram SEZ has resulted in a tragic loss of life. The death toll has reached 17, with 33 others injured. President Murmu and Prime Minister Modi have expressed condolences, and the Prime Minister has announced ex-gratia payments to the families of the deceased.
Zahabiya Khorakiwala, daughter of Habil Khorakiwala, founder of Wockhardt, has taken the reins of the multinational pharmaceutical company’s hospital arm. She oversees Wockhardt Hospitals, a company valued at Rs 9517 crore, and has been instrumental in its growth and expansion. Her journey highlights the leadership and business acumen of the next generation in India’s corporate world.
